R499--MSPO MSPV Support Services

NOTICE OF INTENT TO AWARD AN OUT-OF-SCOPE CONTRACT MODIFICATION Agency: Department of Veterans Affairs (VA) Contracting Activity: Office of Procurement, Acquisition and Logistics (OPAL), Enterprise Procurement Office (EPO) Address: 5202 Presidents Court, Suite 103, Frederick, MD 21703 Contract Number: 36C10X26F0006 Incumbent Contractor: Deloitte Consulting, LLP, 1919 N Lynn Street, Arlington, VA 22209-1742 NAICS Code: 541611 Administrative Management and General Management Consulting Services I. PURPOSE Pursuant to Federal Acquisition Regulation (FAR) 5.201 and applicable Federal Supply Schedule (FSS) ordering procedures, the Department of Veterans Affairs (VA), Strategic Acquisition Center (SAC), on behalf of the VA Medical Supply Program Office (MSPO), hereby provides notice of its intent to modify contract 36C10X26F0006 to increase the level of effort during Option Period 1 (June 26, 2026 December 26, 2026) to a level commensurate with the base period of performance. This notice is being published to afford any interested FSS contractors who believe they are capable of providing the required services the opportunity to submit a capability statement for consideration. II. BACKGROUND Task order 36C10X26F0006 was awarded on December 25, 2025, to Deloitte Consulting, LLP, under GSA Federal Supply Schedule 47QRAA18D001P, for a six-month base period with one six-month option period. The contract provides critical program management, strategic sourcing, clinical integration, and technology support services to the VA Medical Supply Program Office (MSPO) in support of the Medical/Surgical Prime Vendor (MSPV) program, which represents approximately $2.5 billion in annual medical and surgical supply spending serving more than 1,300 VA facilities nationwide. At the time of award, the Government's intent was to draw down contractor support during Option Period 1, reflecting an anticipated reduction in program needs as key activities matured and responsibilities transitioned to Government staff or other contract vehicles. The total contract value, inclusive of base and option periods, is approximately $13,697,624.34. The base period level of effort was substantially greater than that planned for Option Period 1, particularly in the areas of Clinical Product Tool (CPT) managed services and Enterprise Modernization. III. CHANGED CIRCUMSTANCES REQUIRING MODIFICATION Subsequent to contract award, a series of unforeseen events have materially altered the program environment and precluded the planned drawdown of services. These circumstances include: a. Unforeseen Operational Emergencies. During the base period of performance, MSPO encountered unplanned supply disruptions and operational emergencies requiring sustained contractor surge support that was not anticipated at time of award. These events consumed capacity originally allocated toward transitioning work to Government staff, preventing the planned reduction in contractor support. b. Geopolitical Conflict and Associated Supply Chain Disruptions. The conflict in Iran has introduced significant volatility into global medical supply distribution networks, affecting manufacturing, transportation, and raw material inputs for critical medical and surgical products. This has increased the operational burden on MSPO logisticians and contracting personnel, requiring heightened real-time risk monitoring, supplier disruption communications, and field coordination at levels substantially beyond those anticipated during acquisition planning. These activities directly correspond to services provided under Task Areas 5.3 (Program Management) and 5.4 (Enterprise Modernization, Automation, and Innovation) of the Performance Work Statement. c. Increased Compliance Requirements Make PPE in America. Federal emphasis on compliance with the Make Personal Protective Equipment (PPE) in America Act has intensified substantially during the base period, resulting in a materially greater compliance, sourcing, and oversight workload than was projected at the time of award. Implementing these requirements within the MSPV program has required expanded clinically driven strategic sourcing activities, supplier engagement, and regulatory reporting, all of which are within scope of Task Area 5.2 (Clinically Driven Strategic Sourcing) and 5.3 (Program Management). Taken together, these developments have prevented MSPO from achieving the conditions necessary to reduce contractor support, and the program office has determined that continued services at or near the base period level of effort are essential to maintain MSPV program operations, protect Veteran care, and fulfill statutory and regulatory obligations. IV. DESCRIPTION OF PROPOSED MODIFICATION The VA intends to modify contract 36C10X26F0006 to increase the level of effort during Option Period 1 across the following four task areas to a level commensurate with the base period, for a duration of up to six (6) months or through December 26, 2026, whichever occurs first. The modification will adjust Option Period 1 pricing to align with base period monthly rates as established under modification P00001, resulting in an estimated increase in contract value of approximately $6,167,519.94 for the six-month option period, subject to final negotiation and availability of funds. If exercised at the proposed rates, the total estimated value of Option Period 1 would be approximately $9,917,572.14, bringing the total estimated contract value (base plus option, as modified) to approximately $19,865,196.51. Deliverables for Option Period 1 will be updated to reflect the expanded scope consistent with those required during the base period, as described in the Performance Work Statement dated June 17, 2026. V. BASIS FOR OUT-OF-SCOPE DETERMINATION The Government acknowledges that the increase in level of effort beyond what was contemplated at the time of option exercise may constitute a modification outside the scope of the original tas…